Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1205

  • Sort by Relevance to quickly find articles that most closely match your query.
1.

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.

Jordan S, Morris JK, Davies GI, Tucker D, Thayer DS, Luteijn JM, Morgan M, Garne E, Hansen AV, Klungsøyr K, Engeland A, Boyle B, Dolk H.

PLoS One. 2016 Dec 1;11(12):e0165122. doi: 10.1371/journal.pone.0165122.

3.

Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Ailes EC, Simeone RM, Dawson AL, Petersen EE, Gilboa SM.

Birth Defects Res A Clin Mol Teratol. 2016 Nov;106(11):927-934. doi: 10.1002/bdra.23573.

PMID:
27891779
4.

Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit.

Hudon Thibeault AA, Laurent L, Duy SV, Sauvé S, Caron P, Guillemette C, Sanderson JT, Vaillancourt C.

Mol Cell Endocrinol. 2016 Nov 24. pii: S0303-7207(16)30490-7. doi: 10.1016/j.mce.2016.11.021. [Epub ahead of print]

PMID:
27890559
5.

Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan. A nationwide birth cohort study of the Japan Environment and Children's Study.

Nishigori H, Obara T, Nishigori T, Mizuno S, Metoki H, Hoshiai T, Watanabe Z, Sakurai K, Ishikuro M, Tatsuta N, Nishijima I, Fujiwara I, Kuriyama S, Arima T, Nakai K, Yaegashi N; Japan & Environment Children's Study Group..

Congenit Anom (Kyoto). 2016 Nov 23. doi: 10.1111/cga.12202. [Epub ahead of print]

PMID:
27878857
6.

SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.

Bérard A, Sheehy O, Zhao JP, Vinet É, Bernatsky S, Abrahamowicz M.

Br J Clin Pharmacol. 2016 Nov 22. doi: 10.1111/bcp.13194. [Epub ahead of print]

PMID:
27874994
7.

Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.

Brown AS, Gyllenberg D, Malm H, McKeague IW, Hinkka-Yli-Salomäki S, Artama M, Gissler M, Cheslack-Postava K, Weissman MM, Gingrich JA, Sourander A.

JAMA Psychiatry. 2016 Nov 1;73(11):1163-1170. doi: 10.1001/jamapsychiatry.2016.2594.

PMID:
27732704
8.

Maternal environmental risk factors for congenital hydrocephalus: a systematic review.

Kalyvas AV, Kalamatianos T, Pantazi M, Lianos GD, Stranjalis G, Alexiou GA.

Neurosurg Focus. 2016 Nov;41(5):E3.

PMID:
27798989
9.

Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis.

Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K.

Reprod Toxicol. 2016 Dec;66:31-43. doi: 10.1016/j.reprotox.2016.09.013.

PMID:
27667009
10.

Increased symptoms of illness following prenatal stress: Can it be prevented by fluoxetine?

Avitsur R.

Behav Brain Res. 2017 Jan 15;317:62-70. doi: 10.1016/j.bbr.2016.09.021.

PMID:
27633560
11.

Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.

Eke AC, Saccone G, Berghella V.

BJOG. 2016 Nov;123(12):1900-1907. doi: 10.1111/1471-0528.14144. Review.

PMID:
27239775
12.

Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.

Handal M, Skurtveit S, Furu K, Hernandez-Diaz S, Skovlund E, Nystad W, Selmer R.

BJOG. 2016 Nov;123(12):1908-1917. doi: 10.1111/1471-0528.13582.

PMID:
26374234
13.

SSRI exposure in pregnancy linked to speech disorders in offspring.

Wise J.

BMJ. 2016 Oct 12;355:i5536. doi: 10.1136/bmj.i5536. No abstract available.

PMID:
27737832
14.

Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood.

El Marroun H, White TJ, Fernandez G, Jaddoe VW, Verhulst FC, Stricker BH, Tiemeier H.

J Psychopharmacol. 2016 Sep 13. pii: 0269881116665335. [Epub ahead of print]

PMID:
27624153
15.

Antidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic review.

Viuff AC, Pedersen LH, Kyng K, Staunstrup NH, Børglum A, Henriksen TB.

Clin Epigenetics. 2016 Sep 7;8(1):94. doi: 10.1186/s13148-016-0262-x. Review.

16.

Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats.

Sprowles JL, Hufgard JR, Gutierrez A, Bailey RA, Jablonski SA, Williams MT, Vorhees CV.

Int J Dev Neurosci. 2016 Nov;54:39-52. doi: 10.1016/j.ijdevneu.2016.08.007.

PMID:
27591973
17.

Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis.

Kobayashi T, Matsuyama T, Takeuchi M, Ito S.

Reprod Toxicol. 2016 Oct;65:170-178. doi: 10.1016/j.reprotox.2016.07.016.

PMID:
27474253
18.

In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.

Laurent L, Huang C, Ernest SR, Berard A, Vaillancourt C, Hales BF.

Birth Defects Res A Clin Mol Teratol. 2016 Jul 7. doi: 10.1002/bdra.23537. [Epub ahead of print]

PMID:
27384265
19.

Effects of Fluoxetine on Human Embryo Development.

Kaihola H, Yaldir FG, Hreinsson J, Hörnaeus K, Bergquist J, Olivier JD, Åkerud H, Sundström-Poromaa I.

Front Cell Neurosci. 2016 Jun 16;10:160. doi: 10.3389/fncel.2016.00160.

20.

Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.

Hooper CW, Delaney C, Streeter T, Yarboro MT, Poole S, Brown N, Slaughter JC, Cotton RB, Reese J, Shelton EL.

Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H572-81. doi: 10.1152/ajpheart.00822.2015.

PMID:
27371685
Items per page

Supplemental Content

Loading ...
Support Center